Literature DB >> 5541357

The blood-brain barrier for L-dopa in the hypothalamus.

J C De la Torre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5541357     DOI： 10.1016/0022-510x(71)90253-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  4 in total

Review 1.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

2.  Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.

Authors:  U K Rinne; V Sonninen; T Sirtola
Journal:  Z Neurol       Date:  1972

3.  Increased growth hormone response to dopamine infusion in insulin-dependent diabetic subjects: indication of possible blood-brain barrier abnormality.

Authors:  M Lorenzi; J H Karam; M B McIlroy; P H Forsham
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

4.  Studies on the permeability of the blood-brain barrier in experimental diabetes.

Authors:  M Lorenzi; D P Healy; R Hawkins; J M Printz; M P Printz
Journal:  Diabetologia       Date:  1986-01       Impact factor: 10.122
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.